Delivery Order SPE2DX22D0129-SPE2D826F0DEB
- Not listed
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $150,760.44 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- On January 14, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,750.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order is set to be completed by January 15, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,895.86 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a competitively awarded contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,972.77 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was awarded on a non-set-aside, competitive basis. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $6,545.30 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 20, 2026, with performance taking place at AmerSourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,869.95 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This non-competitive delivery order, which concludes on January 13, 2026, is structured as a firm fixed-price contract with performance taking place in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $138,741.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerSourceBergen's substantial...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $67,967.04 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of January 20, 2026, and the work will be performed in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerSourceBergen Drug Corp's larger Indefinite...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,607.64 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded task order under AmerSourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work is scheduled...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DEBDelivery Order
On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,314.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 20, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerSourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a diverse portfolio of pharmaceutical products and medical supplies to federal military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The parent company, Cencora, Inc., maintains an even larger IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, further demonstrating the contractor's significant role in supporting federal pharmaceutical procurement requirements on a competitive, full-and-open basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/18/26 |